PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1983 November; 76(11): 947–956.
PMCID: PMC1439630

Recent developments in acromegaly: a review.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Alberti KG, Christensen NJ, Christensen SE, Hansen AP, Iversen J, Lundbaek K, Seyer-Hansen K, Orskov H. Inhibition of insulin secretion by somatostatin. Lancet. 1973 Dec 8;2(7841):1299–1301. [PubMed]
  • Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) 1980 Jan;12(1):71–79. [PubMed]
  • Aloia JF, Archambeau JO. Hypopituitarism following pituitary irradiation for acromegaly. Horm Res. 1978;9(4):201–207. [PubMed]
  • Arafah BU, Brodkey JS, Kaufman B, Velasco M, Manni A, Pearson OH. Transsphenoidal microsurgery in the treatment of acromegaly and gigantism. J Clin Endocrinol Metab. 1980 Mar;50(3):578–585. [PubMed]
  • Atkinson AB, Allen IV, Gordon DS, Hadden DR, Maguire CJ, Trimble ER, Lyons AR. Progressive visual failure in acromegaly following external pituitary irradiation. Clin Endocrinol (Oxf) 1979 May;10(5):469–479. [PubMed]
  • Baker HL., Jr The angiographic delineation of sellar and parasellar masses. Radiology. 1972 Jul;104(1):67–78. [PubMed]
  • Balagura S, Derome P, Guiot G. Acromegaly: analysis of 132 cases treated surgically. Neurosurgery. 1981 Apr;8(4):413–416. [PubMed]
  • Banna M, Baker HL, Jr, Houser OW. Pituitary and parapituitary tumours on computed tomography. A review article based on 230 cases. Br J Radiol. 1980 Dec;53(636):1123–1143. [PubMed]
  • Barnes AJ, Long RG, Adrian TE, Vale W, Brown MR, Rivier JE, Hanley J, Ghatei MA, Sarson DL, Bloom SR. Effect of a long-acting octapeptide analogue of somatostatin on growth hormone and pancreatic and gastrointestinal hormones in man. Clin Sci (Lond) 1981 Nov;61(5):653–656. [PubMed]
  • Beck P, Parker ML, Daughaday WH. Paradoxical hypersecretion of growth hormone in response to glucose. J Clin Endocrinol Metab. 1966 Apr;26(4):463–469. [PubMed]
  • Belforte L, Camanni F, Chiodini PG, Liuzzi A, Massara F, Molinatti GM, Müller EE, Silvestrini F. Long-term treatment with 2-Br-alpha-ergocryptine in acromegaly. Acta Endocrinol (Copenh) 1977 Jun;85(2):235–248. [PubMed]
  • Besser GM, Mortimer CH, Carr D, Schally AV, Coy DH, Evered D, Kastin AJ, Tunbridge WM, Thorner MO, Hall R. Growth hormone release inhibiting hormone in acromegaly. Br Med J. 1974 Mar 2;1(5904):352–355. [PMC free article] [PubMed]
  • Bicknell RJ, Chapman C. Bombesin stimulates growth hormone secretion from cultured bovine pituitary cells. Neuroendocrinology. 1983;36(1):33–38. [PubMed]
  • Boyd AE, 3rd, Lebovitz HE, Pfeiffer JB. Stimulation of human-growth-hormone secretion by L-dopa. N Engl J Med. 1970 Dec 24;283(26):1425–1429. [PubMed]
  • Konnert JH, Karle J, Ferguson GA. Crystalline ordering in silica and germania glasses. Science. 1973 Jan 12;179(4069):177–179. [PubMed]
  • Brown M, Rivier J, Vale W. Somatostatin: analogs with selected biological activities. Science. 1977 Jun 24;196(4297):1467–1469. [PubMed]
  • Camanni F, Massara F, Belforte L, Rosatello A, Molinatti GM. Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects. J Clin Endocrinol Metab. 1977 Mar;44(3):465–473. [PubMed]
  • Camanni F, Massara F, Fassio V, Molinatti GM, Müller EE. Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects. Neuroendocrinology. 1975;19(3):227–240. [PubMed]
  • Carmina E, Lo Coco R, Lanzara P, Jannì A. Effect of the acute administration of haloperidol and pimozide on plasma GH levels in acromegaly. Acta Endocrinol (Copenh) 1979 Aug;91(4):609–615. [PubMed]
  • Cassar J, Doyle FH, Banks LM, Jadresic A, Mashiter K, Joplin GF. Interstitial pituitary irradiation with 90Y for the treatment of acromegaly. A reappraisal. Acta Endocrinol (Copenh) 1981 Mar;96(3):295–300. [PubMed]
  • Chiodini PG, Liuzzi A, Botalla L, Cremascoli G, Silvestrini F. Inhibitory effect of dopaminergic stimulation on GH release in acromegaly. J Clin Endocrinol Metab. 1974 Feb;38(2):200–206. [PubMed]
  • Christy NP. Choosing the best treatment for acromegaly. JAMA. 1982 Mar 5;247(9):1320–1320. [PubMed]
  • Clark AJ, Mashiter K, Goolden AW, Joplin GF. Hyperprolactinaemia after external irradiation for acromegaly. Clin Endocrinol (Oxf) 1982 Sep;17(3):291–295. [PubMed]
  • Clemmons DR, Underwood LE, Ridgway EC, Kliman B, Kjellberg RN, Van Wyk JJ. Estradiol treatment of acromegaly. Reduction of immunoreactive somatomedin-C and improvement in metabolic status. Am J Med. 1980 Oct;69(4):571–575. [PubMed]
  • Clemmons DR, Van Wyk JJ, Ridgway EC, Kliman B, Kjellberg RN, Underwood LE. Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med. 1979 Nov 22;301(21):1138–1142. [PubMed]
  • Converse JM, Baker DC. Surgical correction of the facial deformities of acromegaly. Ann Plast Surg. 1978 Nov;1(6):612–616. [PubMed]
  • Coppeto JR, Roberts M. Fibrosarcoma after proton-beam pituitary ablation. Arch Neurol. 1979 Jun;36(6):380–381. [PubMed]
  • Cronin MJ, Rogol AD, Dabney LG, Thorner MO. Selective growth hormone and cyclic AMP stimulating activity is present in human pancreatic islet cell tumor. J Clin Endocrinol Metab. 1982 Aug;55(2):381–383. [PubMed]
  • Cryer PE, Daughaday WH. Regulation of growth hormone secretion in acromegaly. J Clin Endocrinol Metab. 1969 Mar;29(3):386–393. [PubMed]
  • Cushing H. III. Partial Hypophysectomy for Acromegaly: With Remarks on the Function of the Hypophysis. Ann Surg. 1909 Dec;50(6):1002–1017. [PubMed]
  • Dabek FT. Bronchial carcinoid tumour with acromegaly in two patients. J Clin Endocrinol Metab. 1974 Feb;38(2):329–333. [PubMed]
  • Daughaday WH, Hall K, Raben MS, Salmon WD, Jr, van den Brande JL, van Wyk JJ. Somatomedin: proposed designation for sulphation factor. Nature. 1972 Jan 14;235(5333):107–107. [PubMed]
  • Daughaday WH, Trivedi B, Kapadia M. Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia. J Clin Endocrinol Metab. 1981 Aug;53(2):289–294. [PubMed]
  • Delitala G, Masala A, Alagna S, Devilla L, Lotti G. Growth hormone and prolactin release in acromegalic patients following metergoline administration. J Clin Endocrinol Metab. 1976 Dec;43(6):1382–1386. [PubMed]
  • Dimond RC, Bramer SR, Atkinson RL, Howard WJ, Earll JM. Chlorpromazine treatment and growth hormone secretory responses in acromegaly. J Clin Endocrinol Metab. 1973 Jun;36(6):1189–1195. [PubMed]
  • DiTullio MV, Jr, Rand RW. Efficacy of cryohypophysectomy in the treatment of acromegaly. Evaluation of 54 cases. J Neurosurg. 1977 Jan;46(1):1–11. [PubMed]
  • Dupont A, Cusan L, Garon M, Labrie F, Li CH. Beta-endorphin: stimulation of growth hormone release in vivo. Proc Natl Acad Sci U S A. 1977 Jan;74(1):358–359. [PubMed]
  • Earll JM, Sparks LL, Forsham PH. Glucose suppression of serum growth hormone in the diagnosis of acromegaly. JAMA. 1967 Aug 21;201(8):628–630. [PubMed]
  • Eastman RC, Gorden P, Roth J. Conventional supervoltage irradiation is an effective treatment for acromegaly. J Clin Endocrinol Metab. 1979 Jun;48(6):931–940. [PubMed]
  • Esch F, Böhlen P, Ling N, Benoit R, Brazeau P, Guillemin R. Primary structure of ovine hypothalamic somatostatin-28 and somatostatin-25. Proc Natl Acad Sci U S A. 1980 Nov;77(11):6827–6831. [PubMed]
  • Faglia G, Beck-Peccoz P, Travaglini P, Paracchi A, Spada A, Lewin A. Elevations in plasma growth hormone concentration after luteinizing hormone-releasing hormone (LRH) in patients with active acromegaly. J Clin Endocrinol Metab. 1973 Aug;37(2):338–340. [PubMed]
  • Faglia G, Paracchi A, Ferrari C, Beck-Peccoz P. Evaluation of the results of trans-sphenoidal surgery in acromegaly by assessment of the growth hormone response to thyrotrophin-releasing hormone. Clin Endocrinol (Oxf) 1978 May;8(5):373–380. [PubMed]
  • Feingold KR, Goldfine ID, Weinstein PR. Acromegaly with normal growth-hormone levels and pituitary histology. Case report. J Neurosurg. 1979 Apr;50(4):503–507. [PubMed]
  • Feldman JM, Plonk JW, Bivens CH. Inhibitory effect of serotonin antagonists on growth hormone release in acromegalic patients. Clin Endocrinol (Oxf) 1976 Jan;5(1):71–78. [PubMed]
  • Frohman LA, Stachura ME. Neuropharmacologic control of neuroendocrine function in man. Metabolism. 1975 Feb;24(2):211–234. [PubMed]
  • Frohman LA, Szabo M, Berelowitz M, Stachura ME. Partial purification and characterization of a peptide with growth hormone-releasing activity from extrapituitary tumors in patients with acromegaly. J Clin Invest. 1980 Jan;65(1):43–54. [PMC free article] [PubMed]
  • Furlanetto RW, Underwood LE, Van Wyk JJ, D'Ercole AJ. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest. 1977 Sep;60(3):648–657. [PMC free article] [PubMed]
  • GOLDBERG MB, SHELINE GE, MALAMUD N. Malignant intracranial neoplasms, following radiation therapy for acromegaly. Radiology. 1963 Mar;80:465–470. [PubMed]
  • Gorden P, Becker CE, Levey GS, Roth J. Efficacy of amino-glutethimide in the ectopic ACTH syndrome. J Clin Endocrinol Metab. 1968 Jun;28(6):921–923. [PubMed]
  • Hall K, Brandt J, Enberg G, Fryklund L. Immunoreactive somatomedin A in human serum. J Clin Endocrinol Metab. 1979 Feb;48(2):271–278. [PubMed]
  • Hall K, McAllister VL. Metrizamide cisternography in pituitary and juxtapituitary lesions. Radiology. 1980 Jan;134(1):101–108. [PubMed]
  • Hall R, Snow M, Scanlon M, Mora B, Gomez-Pan A. Pituitary effects of somatostatin. Metabolism. 1978 Sep;27(9 Suppl 1):1257–1262. [PubMed]
  • Hanew K, Kokubun M, Sasaki A, Mouri T, Yoshinaga K. The spectrum of pituitary growth hormone responses to pharmacological stimuli in acromegaly. J Clin Endocrinol Metab. 1980 Aug;51(2):292–297. [PubMed]
  • Hardy J, Wigser SM. Trans-sphenoidal surgery of pituitary fossa tumors with televised radiofluoroscopic control. J Neurosurg. 1965 Dec;23(6):612–619. [PubMed]
  • Harrison BD, Millhouse KA, Harrington M, Nabarro JD. Lung function in acromegaly. Q J Med. 1978 Oct;47(188):517–532. [PubMed]
  • HARTOG M, DOYLE F, FRASER R, JOPLIN GF. Partial pituitary ablation with implants of gold-198 and yttrium-90 for acromegaly. Br Med J. 1965 Aug 14;2(5458):396–398. [PMC free article] [PubMed]
  • Heitz PU. Multihormonal pituitary adenomas. Horm Res. 1979;10(1):1–13. [PubMed]
  • Hoffenberg R, Howell A, Epstein S, Pimstone BL, Fryklund L, Hall K, Schwalbe S, Rudd BT. Increasing growth with raised circulating somatomedin but normal immunoassayable growth hormone. Clin Endocrinol (Oxf) 1977 Jun;6(6):443–448. [PubMed]
  • Hoyte KM, Martin JB. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy. J Clin Endocrinol Metab. 1975 Oct;41(4):656–659. [PubMed]
  • Irie M, Tsushima T. Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism. J Clin Endocrinol Metab. 1972 Jul;35(1):97–100. [PubMed]
  • Ishibashi M, Yamaji T. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly. J Clin Endocrinol Metab. 1978 Dec;47(6):1251–1256. [PubMed]
  • Jadresic A, Banks LM, Child DF, Diamant L, Doyle FH, Fraser TR, Joplin GF. The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours. Q J Med. 1982 Spring;51(202):189–204. [PubMed]
  • Jadresic A, Poblete M. Stereotaxic pituitary implantation of yttrium-90 and iridium-192 for acromegaly. J Clin Endocrinol Metab. 1967 Oct;27(10):1503–1507. [PubMed]
  • Jaquet P, Guibout M, Jaquet C, Grisoli F, Devolx BC, Dumas D, Bert J. Circadian regulation of growth hormone secretion after treatment in acromegaly. J Clin Endocrinol Metab. 1980 Feb;50(2):322–328. [PubMed]
  • Jonas EA, Aloia JF, Lane FJ. Evidence of subclinical heart muscle dysfunction in acromegaly. Chest. 1975 Feb;67(2):190–194. [PubMed]
  • Jung RT, White MC, Bowley NB, Bydder G, Mashiter K, Joplin GF. CT abnormalities of the pituitary in hyperprolactinaemic women with normal or equivocal sellae radiologically. Br Med J (Clin Res Ed) 1982 Oct 16;285(6348):1078–1081. [PMC free article] [PubMed]
  • Kato Y, Iwasaki Y, Abe H, Ohgo S, Imura H. Effects of endorphins on prolactin and growth hormone secretion in rats. Proc Soc Exp Biol Med. 1978 Jul;158(3):431–436. [PubMed]
  • Kaufmann U, Zapf J, Torretti B, Froesch ER. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo. J Clin Endocrinol Metab. 1977 Jan;44(1):160–166. [PubMed]
  • Klein I, Parveen G, Gavaler JS, Vanthiel DH. Colonic polyps in patients with acromegaly. Ann Intern Med. 1982 Jul;97(1):27–30. [PubMed]
  • Kolodny HD, Sherman L, Singh A, Kim S, Benjamin F. Acromegaly treated with chlorpromazine. A case study. N Engl J Med. 1971 Apr 15;284(15):819–822. [PubMed]
  • Kricheff II. The radiologic diagnosis of pituitary adenoma: an overview. Radiology. 1979 Apr;131(1):263–265. [PubMed]
  • Krulich L. Central neurotransmitters and the secretion of prolactin, GH, LH and TSH. Annu Rev Physiol. 1979;41:603–615. [PubMed]
  • Lamberts SW, Klijn JG, Kwa GH, Birkenhäger JC. The dynamics of growth hormone and prolactin secretion in acromegalic patients with "mixed" pituitary tumours. Acta Endocrinol (Copenh) 1979 Feb;90(2):198–210. [PubMed]
  • Lamberts SW, Liuzzi A, Chiodini PG, Verde S, Klijn JG, Birkenhäger JC. The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly. Eur J Clin Invest. 1982 Apr;12(2):151–155. [PubMed]
  • Lawrence AM, Kirsteins L. Progestins in the medical management of active acromegaly. J Clin Endocrinol Metab. 1970 May;30(5):646–652. [PubMed]
  • Leveston SA, McKeel DW, Jr, Buckley PJ, Deschryver K, Greider MH, Jaffe BM, Daughaday WH. Acromegaly and Cushing's syndrome associated with a foregut carcinoid tumor. J Clin Endocrinol Metab. 1981 Oct;53(4):682–689. [PubMed]
  • Levin SR, Hofeldt FD, Schneider V, Becker N, Karam JH, Seymour RJ, Adams JE, Forsham PH. Cryohypophysectomy for acromegaly. Factors associated with altered endocrine function and carbohydrate metabolism. Am J Med. 1974 Oct;57(4):526–535. [PubMed]
  • Lindholm J, Riishede J, Vestergaard S, Hummer L, Faber O, Hagen C. No effect of bromocriptine in acromegaly: a controlled trial. N Engl J Med. 1981 Jun 11;304(24):1450–1454. [PubMed]
  • Linfoot JA. Alpha particles versus conventional radiotherapy to the pituitary region: a comparison of risk-benefit. Clin Neurosurg. 1980;27:83–98. [PubMed]
  • Liuzzi A, Chiodini PG, Botalla L, Cremascoli G, Müller EE, Silvestrini F. Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration. J Clin Endocrinol Metab. 1974 May;38(5):910–912. [PubMed]
  • Liuzzi A, Chiodini PG, Botalla L, Cremascoli G, Silvestrini F. Inhibitory effect of L-Dopa on GH release in acromegalic patients. J Clin Endocrinol Metab. 1972 Dec;35(6):941–943. [PubMed]
  • Liuzzi A, Chiodini PG, Oppizzi G, Botalla L, Verde G, De Stefano L, Colussi G, Gräf KJ, Horowski R. Lisuride hydrogen maleate: evidence for a long lasting dopaminergic activity in humans. J Clin Endocrinol Metab. 1978 Feb;46(2):196–202. [PubMed]
  • Luboshitzky R, Barzilai D. Hypoxemia and pulmonary function in acromegaly. Am Rev Respir Dis. 1980 Mar;121(3):471–475. [PubMed]
  • Malarkey WB, Daughaday WH. Variable response of plasma GH in acromegalic patients treated with medroxyprogesterone acetate. J Clin Endocrinol. 1971 Sep;33:424–431. [PubMed]
  • Martin JB, Durand D, Gurd W, Faille G, Audet J, Brazeau P. Neuropharmacological regulation of episodic growth hormone and prolactin secretion in the rat. Endocrinology. 1978 Jan;102(1):106–113. [PubMed]
  • Mashiter K, Adams E, Beard M, Holley A. Bromocriptine inhibits prolactin and growth-hormone release by human pituitary tumours in culture. Lancet. 1977 Jul 23;2(8030):197–198. [PubMed]
  • Mather HM, Boyd MJ, Jenkins JS. Heart size and function in acromegaly. Br Heart J. 1979 Jun;41(6):697–701. [PMC free article] [PubMed]
  • McCann SM. Physiology and pharmacology of LHRH and somatostatin. Annu Rev Pharmacol Toxicol. 1982;22:491–515. [PubMed]
  • Meerloo RJ. Surgery in active acromegaly with prognathism and a lateral open bite. Int J Oral Surg. 1981;10(Suppl 1):304–308. [PubMed]
  • Merimee TJ, Zapf J, Froesch ER. Insulin-like growth factors in the fed and fasted states. J Clin Endocrinol Metab. 1982 Nov;55(5):999–1002. [PubMed]
  • Meyers CA, Coy DH, Murphy WA, Redding TW, Arimura A, Schally AV. [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release. Proc Natl Acad Sci U S A. 1980 Jan;77(1):577–579. [PubMed]
  • Mims RB, Bethune JE. Acromegaly with normal fasting growth hormone concentrations but abnormal growth hormone regulation. Ann Intern Med. 1974 Dec;81(6):781–784. [PubMed]
  • MOLINATTI GM, CAMANNI F, MASSARA F, OLIVETTI M, PIZZINI A, GIULIANI G. Implantation of yttrium 90 in the sella turcica in sixteen cases of acromegaly. J Clin Endocrinol Metab. 1962 Jun;22:599–611. [PubMed]
  • Editorial: Conquest of malaria: the art of the feasible. Lancet. 1974 Apr 6;1(7858):607–608. [PubMed]
  • Müller EE, Camanni F, Genazzani AR, Casanueva F, Cocchi D, Locatelli V, Massarå F, Mantegazza P. Dopamine-mimetic and antagonist drugs: diagnostic and therapeutic applications in endocrine disorders. Life Sci. 1981 Aug 31;29(9):867–883. [PubMed]
  • Nakagawa K, Mashimo K. Suppressibility of plasma growth hormone levels in acromegaly with dexamethasone and phentolamine. J Clin Endocrinol Metab. 1973 Aug;37(2):238–246. [PubMed]
  • Pearson OH, Arafah B, Brodkey J. Management of acromegaly. Ann Intern Med. 1981 Aug;95(2):225–227. [PubMed]
  • Touliatos J, Lindholm BW. Treatment of acromegaly by transsphenoidal hypophysectomy with cryoapplication. Clin Endocrinol (Oxf) 1975 Jan;4(1):53–64. [PubMed]
  • Phillips LS, Vassilopoulou-Sellin R. Somatomedins (first of two parts). N Engl J Med. 1980 Feb 14;302(7):371–380. [PubMed]
  • Pieters GF, Romeijn JE, Smals AG, Kloppenborg PW. Somatostatin sensitivity and growth hormone responses to releasing hormones and bromocryptine in acromegaly. J Clin Endocrinol Metab. 1982 May;54(5):942–948. [PubMed]
  • Quabbe HJ. Treatment of acromegaly by trans-sphenoidal operation, 90-yttrium implantation and bromocriptine: results in 230 patients. Clin Endocrinol (Oxf) 1982 Feb;16(2):107–119. [PubMed]
  • Richards SH, Thomas JP. Treatment of acromegaly by transethmoidal hypophysectomy. Q J Med. 1980 Winter;49(193):21–31. [PubMed]
  • Rieu M, Girard F, Bricaire H, Binoux M. The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly. J Clin Endocrinol Metab. 1982 Jul;55(1):147–153. [PubMed]
  • Rinderknecht E, Humbel RE. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem. 1978 Apr 25;253(8):2769–2776. [PubMed]
  • Rinderknecht E, Humbel RE. Primary structure of human insulin-like growth factor II. FEBS Lett. 1978 May 15;89(2):283–286. [PubMed]
  • Rivier C, Brown M, Vale W. Effect of neurotensin, substance P and morphine sulfate on the secretion of prolactin and growth hormone in the rat. Endocrinology. 1977 Mar;100(3):751–754. [PubMed]
  • Rivier C, Rivier J, Vale W. The effect of bombesin and related peptides on prolactin and growth hormone secretion in the rat. Endocrinology. 1978 Feb;102(2):519–522. [PubMed]
  • Rivier C, Vale W, Ling N, Brown M, Guillemin R. Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin. Endocrinology. 1977 Jan;100(1):238–241. [PubMed]
  • ROTH J, GLICK SM, YALOW RS, BERSON SA. THE INFLUENCE OF BLOOD GLUCOSE ON THE PLASMA CONCENTRATION OF GROWTH HORMONE. Diabetes. 1964 Jul-Aug;13:355–361. [PubMed]
  • Rubin AL, Levin SR, Bernstein RI, Tyrrell JB, Noacco C, Forsham PH. Stimulation of growth hormone by luteinizing hormone-releasing hormone in active acromegaly. J Clin Endocrinol Metab. 1973 Jul;37(1):160–162. [PubMed]
  • Sachdev Y, Gomez-Pan A, Tunbridge WM, Duns A, Weightman DR, Hall R, Goolamali SK. Bromocriptine therapy in acromegaly. Lancet. 1975 Dec 13;2(7946):1164–1168. [PubMed]
  • Saeed uz Zafar M, Mellinger RC, Fine G, Szabo M, Frohman LA. Acromegaly associated with a bronchial carcinoid tumor: evidence for ectopic production of growth hormone-releasing activity. J Clin Endocrinol Metab. 1979 Jan;48(1):66–71. [PubMed]
  • Salti IS, Istfan N. Bromocriptine fails to stop growth of eosinophilic adenomas in acromegaly. N Engl J Med. 1979 Aug 16;301(7):386–386. [PubMed]
  • Savage DD, Henry WL, Eastman RC, Borer JS, Gorden P. Echocardiographic assessment of cardiac anatomy and function in acromegalic patients. Am J Med. 1979 Nov;67(5):823–829. [PubMed]
  • Schaison G, Croisier JC, Nathan C, Gilbert-Dreyfus Essai de traitement de l'acromégalie par le sulpiride. Ann Endocrinol (Paris) 1974;35(1):103–110. [PubMed]
  • Schusdziarra V, Ipp E, Harris V, Dobbs RE, Raskin P, Orci L, Unger RH. Studies of the physiology and pathophysiology of the pancreatic D cell. Metabolism. 1978 Sep;27(9 Suppl 1):1227–1232. [PubMed]
  • Schuster LD, Bantle JP, Oppenheimer JH, Seljeskog EL. Acromegaly: reassessment of the long-term therapeutic effectiveness of transsphenoidal pituitary surgery. Ann Intern Med. 1981 Aug;95(2):172–174. [PubMed]
  • Schwartz E, Echemendia E, Schiffer M, Panariello VA. Mechanism of estrogenic action in acromegaly. J Clin Invest. 1969 Feb;48(2):260–270. [PMC free article] [PubMed]
  • Shalet SM, Beardwell CG, MacFarlane IA, Ellison ML, Norman CM, Rees LH, Hughes M. Acromegaly due to production of a growth hormone releasing factor by a bronchial carcinoid tumor. Clin Endocrinol (Oxf) 1979 Jan;10(1):61–67. [PubMed]
  • Smallridge RC, Rajfer S, Davia J, Schaaf M. Acromegaly and the heart. An echocardiographic study. Am J Med. 1979 Jan;66(1):22–27. [PubMed]
  • Sönksen PH, Ayres AB, Braimbridge M, Corrin B, Davies DR, Jeremiah GM, Oaten SW, Lowy C, West TE. Acromegaly caused by pulmonary carcinoid tumours. Clin Endocrinol (Oxf) 1976 Sep;5(5):503–513. [PubMed]
  • Sönksen PH, Greenwood FC, Ellis JP, Lowy C, Rutherford A, Nabarro JD. Changes of carbohydrate tolerance in acromegaly with progress of the disease and in response to treatment. J Clin Endocrinol Metab. 1967 Oct;27(10):1418–1430. [PubMed]
  • Stonesifer LD, Jordan RM, Kohler PO. Somatomedin C in treated acromegaly: poor correlation with growth hormone and clinical response. J Clin Endocrinol Metab. 1981 Nov;53(5):931–934. [PubMed]
  • Summers VK, Hipkin LJ, Diver MH, Davis JC. Treatment of acromegaly with bromocryptine. J Clin Endocrinol Metab. 1975 May;40(5):904–906. [PubMed]
  • Tannenbaum GS. Evidence for autoregulation of growth hormone secretion via the central nervous system. Endocrinology. 1980 Dec;107(6):2117–2120. [PubMed]
  • Tannenbaum GS, Colle E. Ineffectiveness of protamine zinc somatostatin as a long-acting inhibitor of insulin and growth hormone secretion. Can J Physiol Pharmacol. 1980 Aug;58(8):951–955. [PubMed]
  • Teasdale GM, Hay ID, Beasttall GH, McCruden DC, Thomson JA, Davies DL, Grossart KW, Ratcliffe JG. Cryosurgery or microsurgery in the management of acromegaly. JAMA. 1982 Mar 5;247(9):1289–1291. [PubMed]
  • Théron J, Chevalier D, Delvert M, Laffont J. Diagnosis of small and micro pituitary adenomas by intercavernous sinus venography. A preliminary report. Neuroradiology. 1979 Jul 1;18(1):23–30. [PubMed]
  • Thomas JP. Treatment of acromegaly. Br Med J (Clin Res Ed) 1983 Jan 29;286(6362):330–332. [PMC free article] [PubMed]
  • Trovati M, Massara F, Camanni F, Molinatti GM, Lorenzati R, Pagano GF. Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics. J Endocrinol Invest. 1980 Apr-Jun;3(2):189–192. [PubMed]
  • Vale W, Rivier C, Brown M. Regulatory peptides of the hypothalamus. Annu Rev Physiol. 1977;39:473–527. [PubMed]
  • Van Wyk JJ, Svoboda ME, Underwood LE. Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins. J Clin Endocrinol Metab. 1980 Jan;50(1):206–208. [PubMed]
  • Verde G, Chiodini PG, Liuzzi A, Cozzi R, Favales F, Botalla L, Spelta B, Dalla Bonzana D, Rainer E, Horowski R. Effectiveness of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states. J Endocrinol Invest. 1980 Oct-Dec;3(4):405–414. [PubMed]
  • Vigneri R, Goldfine ID. Pharmacologic therapy of patients with pituitary tumors secreting prolactin, growth hormone and adrenocorticotropin. Adv Intern Med. 1980;25:69–89. [PubMed]
  • Waltz TA, Brownell B. Sarcoma: a possible late result of effective radiation therapy for pituitary adenoma. Report of two cases. J Neurosurg. 1966 May;24(5):901–907. [PubMed]
  • Wass JA, Clemmons DR, Underwood LE, Barrow I, Besser GM, Van Wyk JJ. Changes in circulating somatomedin-C levels in bromocriptine-treated acromegaly. Clin Endocrinol (Oxf) 1982 Oct;17(4):369–377. [PubMed]
  • Wass JA, Moult PJ, Thorner MO, Dacie JE, Charlesworth M, Jones AE, Besser GM. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy. Lancet. 1979 Jul 14;2(8133):66–69. [PubMed]
  • Wass JA, Thorner MO, Morris DV, Rees LH, Mason AS, Jones AE, Besser GM. Long-term treatment of acromegaly with bromocriptine. Br Med J. 1977 Apr 2;1(6065):875–878. [PMC free article] [PubMed]
  • Westendorf JM, Schonbrunn A. Bombesin stimulates prolactin and growth hormone release by pituitary cells in culture. Endocrinology. 1982 Feb;110(2):352–358. [PubMed]
  • Whelan J, Redpath T, Buckle R. The medical and anaesthetic management of acromegalic patients undergoing maxillo-facial surgery. Br J Oral Surg. 1982 Jun;20(2):77–83. [PubMed]
  • Williams RA, Jacobs HS, Kurtz AB, Millar JG, Oakley NW, Spathis GS, Sulway MJ, Nabano JD. The treatment of acromegaly with special reference to trans-sphenoidal hypophysectomy. Q J Med. 1975 Jan;44(173):79–98. [PubMed]
  • Wollesen F, Andersen T, Karle A. Size reduction of extrasellar pituitary tumors during bromocriptine treatment. Ann Intern Med. 1982 Mar;96(3):281–286. [PubMed]
  • Wright AD, Hill DM, Lowy C, Fraser TR. Mortality in acromegaly. Q J Med. 1970 Jan;39(153):1–16. [PubMed]
  • Yamaji T, Ishibashi M, Kosaka K, Fukushima T, Hori T, Manaka S, Sano K. Pituitary apoplexy in acromegaly during bromocriptine therapy. Acta Endocrinol (Copenh) 1981 Oct;98(2):171–177. [PubMed]
  • Yen SS, Siler TM, DeVane GW. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels. N Engl J Med. 1974 Apr 25;290(17):935–938. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press